The latest business intelligence report on ‘global immunoprotein diagnostic testing market’ uncovers the ins and outs of this business sphere with respect to the current and past business landscape.
Immunoprotein Diagnostic Testing Market - Overview
The latest business intelligence report on ‘global immunoprotein diagnostic testing market’ uncovers the ins and outs of this business sphere with respect to the current and past business landscape. It lends a competitive edge to businesses and other industry partakers through a comprehensive examination of the industry outlook for 2017-2027, in terms of the driving factors, restraints, opportunities, supply-demand analysis, and competitive benchmarking among others.
According to industry experts, worldwide immunoprotein diagnostic testing industry valuation reached USD 10.1 billion in 2019 and is projected to register a year-over-year growth rate of 6.6% over 2020-2027. Burgeoning cases of infectious and chronic ailments like diabetes, cardiovascular diseases, arthritis, and kidney disorders are the primary growth driver of the industry.
Proceeding further, the research literature segments the industry on the basis of type, applications, technology, and geography. These segments are studied extensively in terms of their revenue share and growth potential. Moreover, the document analyzes the competitive landscape through detailed business profiles comprising of important data points such as strengths & weakness, geographical presence, and growth strategies.
Notably, immunoprotein diagnostic testing identifies the level of immunoprotein in the body such as immunoglobulin, and pre-albumin among others. In recent times, rising inclination towards early diagnostics procedures has raised the significance of immunoprotein tests across the globe.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2942140/
For the record, 9.3% of the global adult population suffered from diabetes in 2019 and is anticipated to increase by 11% in 2045, claims Statista. Likewise, the American population in the age bracket of 65 years old or more was 16% in 2018 and is anticipated to rise by 22% in 2050. Besides, the United Nations, Department of Economic & Social Affairs, states that total number of individuals aged 65 years or above was approximately 703 million in 2019 and is projected to hit 1.5 billion in 2050. Hence, expanding geriatric population who are susceptible to various health conditions is likely to bolster global immunoprotein diagnostic testing market growth in the upcoming years.
On the contrary, stringent regulations are likely to impede the industry expansion over the forecast timeframe, claims the study.
Regional outlook:
North America, Asia Pacific, Latin America, and Europe are the key contributors to global immunoprotein diagnostic testing market remuneration. North America currently holds a coveted position in the industry, attributable to factors such as spike in demand for quick diagnostic services for detection of chronic disorders, rising awareness towards preventive healthcare, and upsurge in the number of drug abuse & allergy cases.
To access a sample pages of this report titled “Global Immunoprotein Diagnostic Testing Market Size study, by Type (C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test and Free Light Chain Diagnostic Test), by Application (Autoimmune Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing and Toxicology Testing), by Technology (Radioimmunoassay, Immunoturbidity Assay, Immunoprotein Electrophoresis, Enzyme-linked immunosorbent assay and Others) and Regional Forecasts 2020-2027” in detail along with the table of contents, please click the link below:
Meanwhile, Asia Pacific immunoprotein diagnostic testing market is set to grow tremendously in the ensuing years, creditable to growing investments in healthcare infrastructure development especially in developing nations, along with presence of large elderly population base in the region.
Global Immunoprotein Diagnostic Testing Market Type Sub-Segments (Revenue, USD Billion, 2017-2027)
- Complement System Protein Diagnostic Test
- C-reactive Protein Diagnostic Test
- Pre-albumin Diagnostic Test
- Immunoglobulin Diagnostic Test
- Haptoglobin Diagnostic Test
- Free Light Chain Diagnostic Test
Global Immunoprotein Diagnostic Testing Market Application Sub-Segments (Revenue, USD Billion, 2017-2027)
- Autoimmune Testing
- Allergy Testing
- Infectious Disease Testing
- Endocrine Testing
- Toxicology Testing
- Oncology Testing
Global Immunoprotein Diagnostic Testing Market Technology Sub-Segments (Revenue, USD Billion, 2017-2027)
- Radioimmunoassay
- Immunoprotein Electrophoresis
- Immunoturbidity Assay
- Enzyme-linked immunosorbent assay
- Others
Global Immunoprotein Diagnostic Testing Market Geographical Fragmentation (Revenue, USD Billion, 2017-2027)
North America
- United States
- Canada
Europe
- United Kingdom
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of APAC
Latin America
- Mexico
- Brazil
Rest of the World
Global Immunoprotein Diagnostic Testing Market Company Profiles (Revenue, USD Billion, 2017-2027)
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers AG
- Roche Diagnostics
- Ortho Clinical Diagnostics
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- Abcam plc
- DiaSorin S.p.A.
- Enzo Life Sciences, Inc.
- Abbott Laboratories
Related Report:
COVID-19 Detection Kits Market Size, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026
The COVID-19 detection kits market is projected to experience a remunerative growth phase over the coming years due to rising coronavirus cases across the globe, and the undertaking of extensive efforts towards the containment of the pandemic. Currently, value and demand for COVID-19 detection kits is continuously rising owing to ongoing industry efforts towards the innovation of more effective detection kits. In fact, the resulting advancements in healthcare technologies is effectively helping the fight towards controlling the spread of novel coronavirus. One of the major factors responsible for helping control the spread of the infection worldwide is testing.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.
Contact Us:
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com